Item Type | Name |
Academic Article
|
Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor.
|
Academic Article
|
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor.
|
Academic Article
|
Design of HIV-1 protease inhibitors active on multidrug-resistant virus.
|
Academic Article
|
Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate.
|
Academic Article
|
Substrate envelope and drug resistance: crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease.
|
Academic Article
|
Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.
|
Academic Article
|
Design of mutation-resistant HIV protease inhibitors with the substrate envelope hypothesis.
|
Academic Article
|
Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2' ligands in pseudosymmetric dipeptide isosteres.
|
Academic Article
|
Viral protease inhibitors.
|
Academic Article
|
Additivity in the analysis and design of HIV protease inhibitors.
|
Academic Article
|
Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease.
|
Academic Article
|
The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.
|
Academic Article
|
Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones.
|
Academic Article
|
Design, synthesis, and biological and structural evaluations of novel HIV-1 protease inhibitors to combat drug resistance.
|
Academic Article
|
Extreme entropy-enthalpy compensation in a drug-resistant variant of HIV-1 protease.
|
Academic Article
|
Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy.
|
Academic Article
|
Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments.
|
Academic Article
|
Covariation of amino acid positions in HIV-1 protease.
|
Academic Article
|
Combating susceptibility to drug resistance: lessons from HIV-1 protease.
|
Academic Article
|
Association of a novel human immunodeficiency virus type 1 protease substrate cleft mutation, L23I, with protease inhibitor therapy and in vitro drug resistance.
|
Academic Article
|
Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity.
|
Academic Article
|
Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands.
|
Academic Article
|
N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure.
|
Academic Article
|
Hydrophobic sliding: a possible mechanism for drug resistance in human immunodeficiency virus type 1 protease.
|
Academic Article
|
Crystal structure of lysine sulfonamide inhibitor reveals the displacement of the conserved flap water molecule in human immunodeficiency virus type 1 protease.
|
Academic Article
|
Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease.
|
Academic Article
|
HIV-1 protease inhibitors from inverse design in the substrate envelope exhibit subnanomolar binding to drug-resistant variants.
|
Academic Article
|
Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
|
Academic Article
|
Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance.
|
Academic Article
|
Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance.
|
Academic Article
|
Rationale for more diverse inhibitors in competition with substrates in HIV-1 protease.
|
Academic Article
|
TMC310911, a novel human immunodeficiency virus type 1 protease inhibitor, shows in vitro an improved resistance profile and higher genetic barrier to resistance compared with current protease inhibitors.
|
Academic Article
|
Decomposing the energetic impact of drug-resistant mutations: the example of HIV-1 protease-DRV binding.
|
Academic Article
|
Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance.
|
Academic Article
|
Interview with Celia Schiffer.
|
Concept
|
HIV Protease Inhibitors
|
Academic Article
|
Testing the substrate-envelope hypothesis with designed pairs of compounds.
|
Academic Article
|
Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance.
|
Academic Article
|
HIV-1 protease-substrate coevolution in nelfinavir resistance.
|
Academic Article
|
Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease.
|
Academic Article
|
Interdependence of Inhibitor Recognition in HIV-1 Protease.
|
Academic Article
|
Elucidating the Interdependence of Drug Resistance from Combinations of Mutations.
|
Academic Article
|
Hydration Structure and Dynamics of Inhibitor-Bound HIV-1 Protease.
|
Academic Article
|
Probing Structural Changes among Analogous Inhibitor-Bound Forms of HIV-1 Protease and a Drug-Resistant Mutant in Solution by Nuclear Magnetic Resonance.
|
Academic Article
|
Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease.
|
Academic Article
|
NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations.
|
Academic Article
|
Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance.
|
Academic Article
|
Target-Specific Prediction of Ligand Affinity with Structure-Based Interaction Fingerprints.
|
Academic Article
|
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope.
|
Academic Article
|
Molecular Determinants of Epistasis in HIV-1 Protease: Elucidating the Interdependence of L89V and L90M Mutations in Resistance.
|
Academic Article
|
Characterizing Protein-Ligand Binding Using Atomistic Simulation and Machine Learning: Application to Drug Resistance in HIV-1 Protease.
|
Academic Article
|
Optimizing the refinement of merohedrally twinned P61 HIV-1 protease-inhibitor cocrystal structures.
|
Academic Article
|
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere.
|
Academic Article
|
Deciphering Complex Mechanisms of Resistance and Loss of Potency through Coupled Molecular Dynamics and Machine Learning.
|
Academic Article
|
Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance.
|
Academic Article
|
HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues.
|